Skystar Bio-Pharmaceutical Company news

   Watch this stock
Showing stories 1 - 10 of about 58   

Articles published

SKBI 2.07 -0.19 (-8.63%)
price chart
Company Shares of Skystar Bio-Pharmaceutical Company Drops by -5.44% | The ...
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) has lost 5.44% during the past week and dropped 26.14% in the last 4 weeks.
The major shareholder of Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI ...
John Gregory is the major shareholder of Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) 2.26 +0.01 0.44% . He lately purchased 35,000 shares in the company with the transaction value amounting to approx.
Skystar Bio-Pharmaceutical Company Stock Upgraded (SKBI)
NEW YORK ( TheStreet) -- Skystar Bio-Pharmaceutical Company (Nasdaq: SKBI) has been upgraded by TheStreet Ratings from sell to hold.
Related articles »  
Skystar Bio-Pharmaceutical Company Announces Receipt of NASDAQ Non-Compliance ...
XI'AN, CHINA--(Marketwired - Apr 15, 2015) - Skystar Bio-Pharmaceutical Company ( NASDAQ : SKBI), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, announced today that the Company ...
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI)'s major shareholder John ...
In a document that's submitted to the U.S. SEC, it was revealed that the major shareholder of Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) 2.26 +0.09 4.00% John Gregory, an insider in focus, made purchase via broker for 38,730 shares of the ...
Skystar Bio-Pharmaceutical Company Downgraded to Hold at TheStreet (SKBI)
Skystar Bio-Pharmaceutical Company logo Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) was downgraded by TheStreet from a “buy” rating to a “hold” rating in a research note issued on Monday.
Skystar Bio-Pharmaceutical Company (SKBI) Q3 2014 Results - Earnings Call ...
Greetings and welcome to the Skystar Bio-Pharmaceutical Unaudited Third Quarter Fiscal 2014 Results Conference Call. At this time, all participants are in a listen-only mode.
Related articles »  
Skystar Bio-Pharmaceutical Company Short Interest Update
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) has witnessed a drop of 37% or 33,584 shares in its short figure. The short interest diminution took it from 90,742 on May 29,2015 to 57,158 on June 15,2015.
Today's Pre-Market Ratings: Skystar Bio Pharmaceutical Company (SKBI ...  WallStreet Scope
Insider Buying: John M. Gregory Acquires 63900 Shares of Skystar Bio ...
Skystar Bio-Pharmaceutical Company logo Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) major shareholder John M. Gregory purchased 63,900 shares of Skystar Bio-Pharmaceutical Company stock on the open market in a transaction dated ...
Short Interest Update of Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI)
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI), A reduction of 17,899 shares or 31.3% was observed in the short interest of Skystar Bio-Pharmaceutical Company The interest on June 30,2015 came in at 39,259 shares and as per the average daily ...
Mid Week Pre-Market Thoughts: Skystar Bio Pharmaceutical Company (SKBI ...  WallStreet Scope